It was reported that CTRa is involved in the activation of known CTR signaling pathways, including the ERK1/2 and p38 MAP kinases, and Ca2+ mobilization, which is typically altered in many cancers, including GBM (Figure 6) [116]. The gene discussed is MAPK3; the disease is cancer.